Somerset, N.J. & CPhI Worldwide, Madrid, Spain – October 14, 2015 — Catalent Pharma Solutions (Stand 3G10), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, consumer health and animal health products, today announced that it has won the ‘Innovation in Process and Formulation Development’ category at the annual CPhI Pharma Awards, for its OptiShell™ softgel technology platform. Softgel capsules have long been recognized by the pharmaceutical community and patients as effective dosage forms for oral drug delivery. Softgels traditionally use gelatin as the film-forming polymer in the capsule shell. The OptiShell softgel technology uses plant-derived polysaccharides providing scientists with new formulation opportunities. The different physico-chemical and thermo-mechanical properties of OptiShell capsules allow for encapsulation of a wider range of fill formulation types including semi-solids formulated at higher temperatures.